LAUSR

Artificial intelligence is becoming more and more important in our life, and therefore also in the practice of our specialization. However, for most of us, it still remains rather obscure how it influences our decisions in clinical care as well as in research. By reading the opening article by Ferrante and colleagues, you will not only be projected into the future but will also get a better understanding on how artificial intelligence already impacts our daily practice.1 The second introductory article in this issue addresses a common problem faced by pediatricians, as registration of medications often comes with restrictions that specifically affect children. The use of pimecrolimus in the treatment of atopic dermatitis in infants is an excellent example of this, which is extensively commented by Luger and colleagues in this rostrum article.2 As one of the official Journals of EAACI, PAI is always delighted to publish position papers developed by EAACI Committees. The one published in this issue on delayed hypersensitivity to antiepileptic drugs in children deserves your full attention.3